[HTML][HTML] Antibody responses in seropositive persons after a single dose of SARS-CoV-2 mRNA vaccine
F Krammer, K Srivastava, H Alshammary… - … England Journal of …, 2021 - Mass Medical Soc
F Krammer, K Srivastava, H Alshammary, AA Amoako, MH Awawda, KF Beach…
New England Journal of Medicine, 2021•Mass Medical SocResponses of Seropositive Persons to a Single SARS-CoV-2 Vaccine Some persons who
have recovered from Covid-19 have antibodies to the spike protein of SARS-CoV-2. In 43
such persons who had received a first mRNA vaccine dose, high levels of neutralizing
antispike antibodies were produced—in many cases even higher than after a second dose
in 67 persons without baseline antibodies to the virus. Systemic reactions were more
common in those seropositive before vaccination.
have recovered from Covid-19 have antibodies to the spike protein of SARS-CoV-2. In 43
such persons who had received a first mRNA vaccine dose, high levels of neutralizing
antispike antibodies were produced—in many cases even higher than after a second dose
in 67 persons without baseline antibodies to the virus. Systemic reactions were more
common in those seropositive before vaccination.
Responses of Seropositive Persons to a Single SARS-CoV-2 Vaccine
Some persons who have recovered from Covid-19 have antibodies to the spike protein of SARS-CoV-2. In 43 such persons who had received a first mRNA vaccine dose, high levels of neutralizing antispike antibodies were produced — in many cases even higher than after a second dose in 67 persons without baseline antibodies to the virus. Systemic reactions were more common in those seropositive before vaccination.
The New England Journal Of Medicine